Sydney Sawyier

Associate
Full contact info

Passions

Playing the violin and piano

Film

Muay thai

Cooking

Skiing

Experience

Clinical Microbiomics and CosmosID Merge To Create Global Leader in Microbiome Research Services

October 11, 2023

Cooley advised Clinical Microbiomics, a leading innovator in bioinformatics and systems biology for the microbiome field based in Copenhagen, on its merger with CosmosID, a leading CLIA-certified, GxP-compliant microbiome contract research organization based in Maryland. 

Read more

Related contacts

Rita Sobral
Associate, London
Sydney Sawyier
Associate, London
Vlad Herta
Associate, London

Related Practices & Industries

VectivBio to be Acquired by Ironwood

May 23, 2023

Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by Ironwood, with an estimated aggregate consideration of approximately $1 billion.

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Rita Sobral
Associate, London
Sydney Sawyier
Associate, London
Vlad Herta
Associate, London
Sarah Curry
Associate, New York
Trevor Bossi
Associate, Boston
Lois NaYeon Yoo
Associate, New York
Ofir Hadari
Associate, New York
David Burns
Special Counsel, Washington, DC
Nicollette R. Kirby
Associate, Washington, DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Mary Maher Lewis
Special Counsel, Reston
Steven A. Zuckerman
Associate, New York
Stephanie Gentile
Partner, New York
Eileen Marshall
Partner, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Ivor Elrifi
Partner, New York
Heidi A. Erlacher
Partner, Boston
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Megan Flynn
Associate, London
Joe Claffey
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

Bavarian Nordic Acquires Emergent BioSolutions Travel Vaccines Portfolio

February 22, 2023

Bavarian Nordic, a vaccine company, has entered into a definitive agreement to acquire Emergent BioSolutions’ travel vaccines portfolio for up to $380 million, including an upfront payment of $270 million.

Read more

Related contacts

John Wilkinson
Partner, London
Jarrett Burks
Associate, London
Joe Sandys
Associate, London
Michael Fernando
Associate, London
Sydney Sawyier
Associate, London

Admissions & credentials

New York